SOTOXA
LIVE

Serial Number

79263441

Owner

Alere Toxicology plc

Attorney

Michele H. Bowman

Filing Date

Feb 27, 2019

Add to watchlist:

No watchlists yet
View on USPTO

SOTOXA Trademark

Serial Number: 79263441 • Registration: 6098334

SOTOXA is a trademark filed by Alere Toxicology plc on February 27, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Alere Toxicology plc (5 trademarks)

92 Milton Park, Milton,

Entity Type: 99

Abbott Toxicology Limited (2 trademarks)

21 Blacklands Way

Entity Type: 99

Trademark Details

Filing Date

February 27, 2019

Registration Date

July 14, 2020

Published for Opposition

April 28, 2020

Goods & Services

Downloadable software for downloading, storing, managing, analyzing, reporting, and printing drug test data in the fields of fields of toxicology, forensics, and drug testing; downloadable mobile application software for reading, recording, sharing, reporting, maintaining, managing, monitoring and analyzing data and information in the fields of fields of toxicology, forensics, and drug testing; downloadable software for downloading, storing, managing, analyzing, reporting, and printing drug test data; battery chargers for use with drug testing systems; printers for sale as part of drug testing systems; forensic drug analyzer system consisting primarily of electronic chemical analyzers, not for medical purposes; electronic immunodiagnostic apparatus and instruments for the detection of drugs of abuse, not for medical purposes; electronic drug testing apparatus and instruments, not for medical purposes; drug testing systems comprising non-medical electronic testing apparatus not for medical purposes

Diagnostic reagents and chemical reagents, for medical purposes; medical diagnostic and immunodiagnostic reagents, for medical purposes; drug testing kits comprising reagents and assays, for medical purposes; drug testing kits comprised of diagnostic reagents and assays for testing body fluids, for medical purposes; drug testing systems comprising reagents and assays, for medical purposes; kits comprising reagents and assays for testing for the presence of analytes in biological fluids, other fluids and other matrices, for medical purposes; kits comprising reagents and assays for collecting and testing oral fluid for the presence of drugs and drug metabolites, for medical purposes

Diagnostic reagents and chemical reagents, not for medical purposes; immunodiagnostic reagents, not for medical purposes; buffer solutions, not for medical purposes; immunoassay test strips, not for medical purposes; drug testing kits comprising reagents and assays, not for medical purposes; drug testing kits comprised of diagnostic reagents and assays for testing body fluids, not for medical purposes; drug testing systems comprising reagents and assays, not for medical purposes; kits comprising reagents and assays for testing for the presence of analytes in biological fluids, other fluids and other matrices, not for medical purposes; kits comprising reagents and assays for collecting and testing oral fluid for the presence of drugs and drug metabolites, not for medical purposes

Medical drug testing services; medical toxicology services

Medical apparatus and instruments, namely, analyzers for the screening of drugs; medical diagnostic and immunodiagnostic apparatus and instruments, namely, analyzers for the screening of drugs; drug testing analyzers for medical purposes; drug testing cartridges adapted for use with electronic medical testing analyzers for medical purposes; drug testing cartridges comprised of immunoassay test strips adapted for use with electronic medical testing analyzers for medical purposes; chromatographic immunoassay test cartridges adapted for use with electronic medical testing analyzers for medical purposes; drug testing systems comprising medical testing apparatus for medical purposes; medical drug testing kits comprising medical testing apparatus; kits comprising medical apparatus for testing for the presence of analytes in biological fluids, other fluids and other matrices, all for medical purposes; kits comprising medical apparatus for collecting and testing oral fluid for the presence of drugs and drug metabolites, for medical use

Software as a service (SAAS) featuring software for scientific purposes for toxicology reporting in the fields of forensics and drug testing; software as a service (SAAS) featuring software for scientific purposes for facilitating testing and analysis in the fields of forensics and drug testing; hosting a website featuring online databases for the provision of information in the fields of toxicology, forensics, and drug testing; providing updates for software; laboratory toxicology services; laboratory drug testing services; design and development of computer software for use with medical and non-medical technology

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jan 3, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 5, 2024 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 12, 2021 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 28, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 6, 2020 FICS
FINAL DISPOSITION PROCESSED
Nov 6, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 14, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 14, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 28, 2020 NPUB
PUBLISHED FOR OPPOSITION
Apr 28, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 8, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 20, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 20, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 20, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 20, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 20, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 13, 2020 CRFA
ASSIGNED TO LIE
Mar 13, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 9, 2020 TROA
REFUSAL PROCESSED BY IB
Sep 27, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 9, 2019 RFCS
REFUSAL PROCESSED BY MPU
Sep 9, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 22, 2019 RFCR
NON-FINAL ACTION WRITTEN
Aug 21, 2019 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Aug 19, 2019 RFWR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Aug 1, 2019 ADCH
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 27, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jul 26, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 26, 2019 MAFR
ASSIGNED TO EXAMINER
Jul 22, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 22, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 18, 2019 REPR